Show simple item record

FieldValueLanguage
dc.contributor.authorGao, Antony
dc.date.accessioned2024-06-03T23:26:55Z
dc.date.available2024-06-03T23:26:55Z
dc.date.issued2023en_AU
dc.identifier.urihttps://hdl.handle.net/2123/32617
dc.descriptionIncludes publication
dc.description.abstractSerum amyloid A (SAA) is an acute-phase apolipoprotein, synthesised in response to pro-inflammatory states and may be a useful biomarker for inflammatory disease within the body. SAA may also contribute to pro-inflammatory signalling, exacerbate pro-atherogenic pathophysiological cascades and induce endothelial dysfunction. Cyclic nitroxides, antioxidants which scavenges free radicals, may mitigate endothelial dysfunction and therefore may provide renoprotective/cardioprotective benefits. The current study utilises an atherosclerosis-prone murine model (ApoE-/-) and administration of SAA with cyclic nitroxide antioxidant 4-Methoxy-TEMPO co-supplementation. Histological and biochemical studies were conducted to better define the pathophysiological signalling behind SAA-mediated renal injury, pro-atherogenic activity and the effects of cyclic nitroxide antioxidants upon those cascades. Administration of SAA results in renal injury, implicating both inflammatory and immune cascades, notably Nrf2, NF-B, p38 MAPK and IFN-. Upregulation of pro-inflammatory and pro-immune factors were primarily co-localised to the tubular nuclei of the renal nephron with relative sparing of the glomeruli nuclei. Downstream, this led to acutely increased expression of iNOS within the parietal epithelium of the glomeruli and tubular epithelium. Together, upregulation of the above factors resulted in increased renal fibrosis in the periglomerular and renal interstitium in the long-term. Furthermore, there was an association with increased plaque size and vulnerability with SAA, signifying increased risk of adverse cardiovascular outcomes. Supplementation with 4-Methoxy-TEMPO was unable to dampen SAA signalling nor mitigate SAA-mediated renal injury/dysfunction, however, features of increased plaque stability were observed. Further studies exploring the effects of cyclic nitroxides on plaque stabilisation in models of plaque rupture will be valuable to corroborate the current data.en_AU
dc.language.isoenen_AU
dc.subjectnitroxidesen_AU
dc.subjectendothelial dysfunctionen_AU
dc.subjectatherosclerosisen_AU
dc.subjectserum amyloid Aen_AU
dc.titleRole for cyclic nitroxides in protecting renal function from Serum Amyloid A stimulated renal injuryen_AU
dc.typeThesis
dc.type.thesisMasters by Researchen_AU
dc.rights.otherThe author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission.en_AU
usyd.facultySeS faculties schools::Faculty of Medicine and Health::School of Medical Sciencesen_AU
usyd.degreeMaster of Philosophy M.Philen_AU
usyd.awardinginstThe University of Sydneyen_AU
usyd.advisorWITTING, PAUL
usyd.include.pubYesen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.